Literature DB >> 5331304

The long-acting thyroid stimulator.

K J Dorrington, D S Munro.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 5331304     DOI： 10.1002/cpt196676788

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  6 in total

Review 1.  The thyrotropin receptor and its role in Graves' disease.

Authors:  B Rees Smith; C R Rickards; E Davies Jones; Y Kajita; P R Buckland; F M Creagh; R D Howells; F Hashim; A B Parkes; V B Petersen
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

2.  Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.

Authors:  N Benhamou-Glynn; D J el-Kabir; D Doniach; I M Roitt
Journal:  Proc R Soc Med       Date:  1968-12-12

3.  Studies on the antigen reacting with the thyroid-stimulating immunoglobulin (LATS) in thyrotoxicosis.

Authors:  N Benhamou-Glynn; D J el-Kabir; I M Roitt; D Doniach
Journal:  Immunology       Date:  1969-02       Impact factor: 7.397

4.  A comparison of the actions of thyroid-stimulating hormone and the long-acting thyroid stimulator in an in vitro assay.

Authors:  J Brown; J Ensor; D S Munro
Journal:  Proc R Soc Med       Date:  1968-07

5.  [The long-acting thyroid stimulator (LATS) in untreated and I-131 treated hyperthyreoses, following total thyroidectomy, as well as its relation to thyroid antibodies].

Authors:  A Ziemke; L Weisbecker; H Uthgenannt; K Schemmel; W Müller; H Heesen; W Eickenbusch
Journal:  Klin Wochenschr       Date:  1968-10-01

6.  Targeting QKI-7 in vivo restores endothelial cell function in diabetes.

Authors:  Chunbo Yang; Magdalini Eleftheriadou; Sophia Kelaini; Thomas Morrison; Marta Vilà González; Rachel Caines; Nicola Edwards; Andrew Yacoub; Kevin Edgar; Arya Moez; Aleksandar Ivetic; Anna Zampetaki; Lingfang Zeng; Fiona L Wilkinson; Noemi Lois; Alan W Stitt; David J Grieve; Andriana Margariti
Journal:  Nat Commun       Date:  2020-07-30       Impact factor: 14.919
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.